Securities Registration: Employee Benefit Plan (s-8)
30 Dezembro 2021 - 6:32PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on December 30, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933
Xenetic
Biosciences, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Nevada
|
|
45-2952962
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
40 Speen Street, Suite 102
Framingham, Massachusetts
|
|
01701
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Amended and Restated Equity Incentive Plan
(Full title of the plan)
James F. Parslow
Chief Financial Officer
Xenetic Biosciences, Inc.
40 Speen Street, Suite 102
Framingham, Massachusetts, 01701
(781) 778-7720
(Name, address and telephone number, including
area code, of agent for service)
With a copy to:
|
Danielle Price
Holland-Knight LLP
701 Brickell Avenue, Suite 3300
Miami, Florida 33131
(305) 374-8500
|
K. Elisabeth Castro
Westward Law, LLC
3273 E. Warm Springs Rd.
Las Vegas, NV 89120
(702) 701-3945
|
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨
|
Accelerated filer ¨
|
Non-accelerated filer ý
|
Smaller reporting company ý
|
Emerging growth company ¨
|
|
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. ¨
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
|
Amount to be Registered (1)
|
Proposed Maximum
Offering
Price Per Share(2)
|
Proposed Maximum
Aggregate
Offering Price(2)
|
Amount of
Registration Fee
|
Common Stock, par value $0.001 per share
|
1,500,000 shares
|
$1.43
|
$2,145,000.00
|
$198.84
|
(1)
|
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, par value $0.001 (the “Common Stock”) that become issuable under the Registrant’s Amended and Restated Equity Incentive Plan (the “Amended and Restated EIP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock.
|
(2)
|
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering price are based upon $1.43, which is the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Capital Market on December 23, 2021.
|
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being
filed for the purpose of registering an additional 1,500,000 shares of common stock, par value $0.001 per share (the “Common Stock”)
of the Registrant reserved for future issuance under the Xenetic Biosciences, Inc. Amended and Restated Equity Incentive Plan (the “Amended
and Restated EIP”). The additional shares of Common Stock being registered pursuant to the Amended and Restated EIP are additional
securities under the same class as other securities for which registration statements (File No. 333- 218024, File No. 333-222272 and File
No. 333-237529) on Form S-8 were filed with the Securities and Exchange Commission (the “Commission”) on May 16, 2017, December
22, 2017 and April 1, 2020, respectively (the “Prior Registration Statements”). Pursuant to Instruction E of Form S-8, the
contents of the Prior Registration Statements are incorporated herein by reference.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified in Item 1 and Item 2
of Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under the Securities Act.
The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the plans covered by
this Registration Statement as specified by Rule 428(b)(1) under the Securities Act. These documents and the documents incorporated by
reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a Prospectus
that meets the requirements of Section 10(a) of the Securities Act.
PART II
INCORPORATION OF DOCUMENTS BY REFERENCE
|
ITEM 3.
|
INCORPORATION OF DOCUMENTS BY REFERENCE
|
The following documents filed by the Registrant
with the Commission are incorporated by reference to this Registration Statement:
(a) The Registrant’s Annual Report on Form
10-K (File No. 001-37937) for the fiscal year ended December 31, 2020, filed with the Commission on March 16, 2021, as amended by the
Form 10-K/A filed with the Commission on April 28, 2021;
(b) All other reports filed pursuant to Section
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since the end of the fiscal year covered
by the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as amended; and
(c) The description of the Registrant’s Common
Stock contained in the Registrant’s Registration Statement on Form 8-A/A filed on November 1, 2016 (File No. 001-37937), under the
Exchange Act, including any amendment or report filed for the purpose of updating such description.
All other reports and documents subsequently filed
by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement
and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be
a part of this Registration Statement from the date of the filing of such reports and documents; provided, however, that documents, reports
and definitive proxy or information statements, or portions thereof, which are furnished and not filed in accordance with the rules of
the Commission shall not be deemed incorporated by reference into this Registration Statement.
Any statement contained in a document incorporated
or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference
herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration Statement.
|
ITEM 4.
|
DESCRIPTION OF SECURITIES
|
Not applicable.
|
ITEM 5.
|
INTERESTS OF NAMED EXPERTS AND COUNSEL
|
Not applicable.
|
ITEM 6.
|
INDEMNIFICATION OF DIRECTORS AND OFFICERS
|
Nevada law provides that a Nevada corporation
may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed proceeding,
except an action by or in the right of the corporation, by reason of the fact that such person is or was a director, officer, employee
or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually
and reasonably incurred by such person in connection with the proceeding, if such person:
|
·
|
is not liable for breach of his or her fiduciary duties to the corporation; or
|
|
·
|
acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.
|
In addition, a Nevada corporation may indemnify
any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action by or in the right
of the corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
corporation or other enterprise against expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably
incurred by such person in connection with the defense or settlement of the action, if he or she:
|
·
|
is not liable for breach of his or her fiduciary duties to the corporation; or
|
|
·
|
acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation.
|
Under Nevada law, indemnification may not be made
for any claim as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom,
to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that a court of competent
jurisdiction determines that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for
such expenses as the court deems proper.
To the extent that a director, officer, employee
or agent of a corporation has been successful on the merits or otherwise in defense of any non-derivative proceeding or any derivative
proceeding, or in defense of any claim, issue or matter therein, the corporation shall indemnify such person against expenses, including
attorneys’ fees, actually and reasonably incurred in connection with the defense.
Further, Nevada law permits a Nevada corporation
to purchase and maintain insurance or to make other financial arrangements on behalf of any person who is or was a director, officer,
employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent
of another corporation or other enterprise for any liability asserted against him or her and liability and expenses incurred by him or
her in his or her capacity as a director, officer, employee or agent, or arising out of his or her status as such, whether or not the
corporation has the authority to indemnify such person against such liability and expenses.
Under our charter and bylaws, we are obligated
to indemnify any director, officer, employee or agent of the company to the fullest extent permitted by the Nevada Revised Statues (“NRS”),
as described above. We have entered into separate indemnification agreements with our directors and executive officers, in addition to
the indemnification provided for in our charter and bylaws. These agreements, among other things, require us to indemnify our directors
and executive officers who have met the standards of conduct that make it permissible under the NRS for us to indemnify the claimant for
certain expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by such person in any action or proceeding
arising out of their services as one of our directors, officers, employees or agents, or any of our subsidiaries or any other company
or enterprise to which the person provides services at our request. We believe that these charter and bylaw provisions and indemnification
agreements are necessary to attract and retain qualified persons as directors.
In addition, indemnification is required to continue
as to a person who has ceased to be a director or officer and inures to the benefit of his or her heirs, executors and administrators.
Subject to the exceptions detailed below, we may indemnify a person seeking indemnification in connection with a proceeding (or part thereof)
initiated by the person seeking indemnification only if the proceeding (or part thereof) was authorized by our board of directors. We
may indemnify any employee or agent of us to an extent greater than required by law only if and to the extent that our directors, in their
discretion, may determine.
If we do not pay a claim for indemnification within
60 days after a written claim has been received by us or pay an advancement of expenses under our bylaws in full within 20 days after
a written claim has been received by us, the claimant may bring suit against us to recover the unpaid amount of the claim and, if successful
in whole or in part, the claimant also will be entitled to be paid the expense of prosecuting such claim to the fullest extent permitted
by applicable law. In any such action, we would have the burden of proving that the claimant is not entitled to the requested indemnification
or advancement of expenses.
|
ITEM 7.
|
EXEMPTION FROM REGISTRATION CLAIMED
|
Not applicable.
The following exhibits are filed herewith:
1. The Registrant hereby undertakes:
(a) To file, during any period in which offers
or sales are being made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by section
10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change
in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration
statement.
(iii) To include any material information with respect
to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement;
Provided, however, that paragraphs (a)(i)
and (a)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in
reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are
incorporated by reference in the registration statement.
(b) That, for the purpose of determining any liability
under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.
2. The Registrant hereby undertakes that, for purposes of determining
any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d)
of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating
to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
3. Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise,
the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy
as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Framingham, Commonwealth of Massachusetts, on December 30, 2021.
|
|
|
|
|
XENETIC BIOSCIENCES, INC.
|
|
|
|
|
By:
|
|
/s/ James Parslow
|
|
|
|
James Parslow
|
|
|
|
Chief Financial Officer
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE
PRESENTS, that each person whose signature appears below constitutes and appoints Jeffrey Eisenberg or James Parslow, and each of them
singly, as his or her true and lawful attorney-in-fact and agent, with the full power of substitution, for him or her and in his or her
name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective
amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite
and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done
by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and
on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/S/ JEFFREY EISENBERG
Jeffrey Eisenberg
|
|
Chief Executive Officer and Director
(Principal Executive Officer)
|
|
December 30, 2021
|
|
|
|
|
|
/S/ JAMES PARSLOW
James Parslow
|
|
Chief Financial Officer
(Principal Financial Officer, Principal Accounting
Officer)
|
|
December 30, 2021
|
|
|
|
|
|
/S/ GRIGORY BORISENKO
Grigory Borisenko
|
|
Director
|
|
December 30, 2021
|
|
|
|
|
|
/S/ JAMES E. CALLAWAY
James E. Callaway
|
|
Director
|
|
December 30, 2021
|
|
|
|
|
|
/S/ FIRDAUS JAL DASTOOR
Firdaus Jal Dastoor
|
|
Director
|
|
December 30, 2021
|
|
|
|
|
|
/S/ ROGER KORNBERG
Roger Kornberg
|
|
Director
|
|
December 30, 2021
|
|
|
|
|
|
/S/ ADAM LOGAL
Adam Logal
|
|
Director
|
|
December 30, 2021
|
|
|
|
|
|
/S/ ALEXEY VINOGRADOV
Alexey Vinogradov
|
|
Director
|
|
December 30, 2021
|
Xenetic Biosciences (NASDAQ:XBIO)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Xenetic Biosciences (NASDAQ:XBIO)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025